Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Berthelot JM et al. - The identification of other joint-specific antigens, like gp-39, in HC and medullary epithelial cells, would provide new insights into the mechanisms of RA pathogenesis and may lead to more specific and physiologic methods of immunomodulation.

Related Articles

Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: A 3-month, randomized, double-blind, placebo-controlled trial
Clinical Therapeutics, 10/15/09    Relevance Score: 71%

Certolizumab Pegol: In Rheumatoid Arthritis
BioDrugs, 11/11/09    Relevance Score: 70%

Assistive technology for rheumatoid arthritis
Cochrane Reviews, 10/09/09    Relevance Score: 70%

Treatment of early RA with infliximab is beneficial
American Pharmacists Association, 11/06/09    Relevance Score: 69%

Abatacept for rheumatoid arthritis
Cochrane Reviews, 10/09/09    Relevance Score: 69%

Today in Rheumatic/Autoimmune...keeping you current

The sympathetic nervous system modulates CD4+FoxP3+ regulatory T cells via a TGF-[beta]-dependent mechanism
Journal of Leukocyte Biology, 12/15/09

Autoantibodies against C1q in Systemic Lupus Erythematosus Are Antigen-Driven
Journal of Immunology, 12/15/09

Is There a Role for B-cell Depletion as Therapy for Scleroderma? A Case Report and Review of the Literature
Seminars in Arthritis and Rheumatism, 12/15/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address